The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching

被引:107
作者
Jabara, HH
Laouini, D
Tsitsikov, E
Mizoguchi, E
Bhan, AK
Castigli, E
Dedeoglu, F
Pivniouk, V
Brodeur, SR
Geha, RS [1 ]
机构
[1] Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Immunopathol Unit, Boston, MA 02115 USA
关键词
D O I
10.1016/S1074-7613(02)00394-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To define the role of TRAF proteins in CD40-dependent isotype switching in B cells, we introduced wild-type (WT) and mutant CD40 transgenes that lacked the binding motifs for TRAF6 (CD40DeltaTRAF6), TRAF2 and TRAF3 (CD40DeltaTRAF2/3), or both (CD40DeltaTRAFs) into B cells of CD40(-/-) mice. The in vivo isotype switch defect in CD40(-/-) mice was fully corrected by WT and CD40Delta TRAF6, partially by CD40DeltaTRAF2/3, and not at all by CD40DeltaTRAFs transgenes. CD40-mediated isotype switching, proliferation, and activation of p38, JNK, and NFkappaB in B cells were normal in WT and CD40DeltaTRAF6 mice, severely impaired in CD40DeltaTRAF2/3, and absent in CD40DeltaTRAFs mice. These results suggest that binding to TRAF2 and/or TRAF3 but not TRAF6 is essential for CD40 isotype switching and activation in B cells.
引用
收藏
页码:265 / 276
页数:12
相关论文
共 53 条
[31]  
Nagumo H, 1998, J IMMUNOL, V161, P6496
[32]   Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice [J].
Naito, A ;
Azuma, S ;
Tanaka, S ;
Miyazaki, T ;
Takaki, S ;
Takatsu, K ;
Nakao, K ;
Nakamura, K ;
Katsuki, M ;
Yamamoto, T ;
Inoue, J .
GENES TO CELLS, 1999, 4 (06) :353-362
[33]   Targeted disruption of Traf5 gene causes defects in CD40-and CD27-mediated lymphocyte activation [J].
Nakano, H ;
Sakon, S ;
Koseki, H ;
Takemori, T ;
Tada, K ;
Matsumoto, M ;
Munechika, E ;
Sakai, T ;
Shirasawa, T ;
Akiba, H ;
Kobata, T ;
Santee, SM ;
Ware, CF ;
Rennert, PD ;
Taniguchi, M ;
Yagita, H ;
Okumura, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (17) :9803-9808
[34]   TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses [J].
Nguyen, LT ;
Duncan, GS ;
Mirtsos, C ;
Ng, M ;
Speiser, DE ;
Shahinian, A ;
Marino, MW ;
Mak, TW ;
Ohashi, PS ;
Yeh, WC .
IMMUNITY, 1999, 11 (03) :379-389
[35]   CD40-Tumor necrosis factor receptor-associated factor (TRAF) interactions: Regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization [J].
Pullen, SS ;
Miller, HG ;
Everdeen, DS ;
Dang, TTA ;
Crute, JJ ;
Kehry, MR .
BIOCHEMISTRY, 1998, 37 (34) :11836-11845
[36]   TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-κB activation [J].
Pype, S ;
Declercq, W ;
Ibrahimi, A ;
Michiels, C ;
Van Rietschoten, JGI ;
Dewulf, N ;
de Boer, M ;
Vandenabeele, P ;
Huylebroeck, D ;
Remacle, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (24) :18586-18593
[37]   Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2 [J].
Reinhard, C ;
Shamoon, B ;
Shyamala, V ;
Williams, LT .
EMBO JOURNAL, 1997, 16 (05) :1080-1092
[38]  
Revy P, 1999, J IMMUNOL, V163, P787
[39]  
Richards ML, 1997, J IMMUNOL, V158, P263
[40]   TRAF2-MEDIATED ACTIVATION OF NF-KAPPA-B BY TNF RECEPTOR-2 AND CD40 [J].
ROTHE, M ;
SARMA, V ;
DIXIT, VW ;
GOEDDEL, DV .
SCIENCE, 1995, 269 (5229) :1424-1427